Frank Mottola sold $555K of Supernus Pharmaceuticals (SUPN)

Executed Nov 7 2024, disclosed Nov 8 2024, 1 day later.

Value, as filed

$555K

15,000 sh × $36.98

Executed

Nov 7 2024

the trade date, as filed

Disclosed

Nov 8 2024

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

FM Frank Mottola SVP, Quality, GMP, Ops, IT profile →

Frank Mottola (SVP, Quality, GMP, Ops, IT) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in SUPN. The largest single filing was $1.0M of SUPN (20,000 sh across 2 lots, as filed), executed Dec 19 2025.

The name

SUPN SUPN SUPN · 38 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Frank Mottola in SUPN

SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $1.0M
20,000 sh across 2 lots
Exec Dec 19 2025
Filed Dec 22 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $229K
5,000 sh × $45.87
Exec Sep 12 2025
Filed Sep 15 2025 · 5:30 PM ET SUPNSALE SUPERNUS PHARMACEUTICALS, INC. $623K
14,000 sh × $44.51
Exec Aug 25 2025
Filed Aug 27 2025 · 5:30 PM ET